A first-in-human study of AO-176, a highly differentiated anti-CD47 antibody, in patients with advanced solid tumors.

被引：17

作者：

Burris, Howard A., III

Spira, Alexander I.

Taylor, Matthew H.

Yeku, Oladapo O.

Liu, Joyce F.

Munster, Pamela N.

Hamilton, Erika P.

Thomas, Jacob Stephen

Gatlin, Frances

Penson, Richard T.

Abrams, Thomas Adam

Dhawan, Mallika Sachdev

Walling, Jacqueline M.

Frye, John W.

Romanko, Kevin

Sung, Victoria

Brachmann, Carrie

El-Khoueiry, Anthony B.

机构：

[1] Sarah Cannon Res Inst, Nashville, TN USA

[2] Tennessee Oncol PLLC, Nashville, TN USA

[3] Virginia Canc Specialists, US Oncol Res, Fairfax, VA USA

[4] Providence Canc Inst, Portland, OR USA

[5] Massachusetts Gen Hosp, Boston, MA 02114 USA

[6] Dana Farber Canc Inst, Boston, MA 02115 USA

[7] Univ Calif San Francisco, San Francisco, CA 94143 USA

[8] USC, Div Oncol, Keck Sch Med, Norris Comprehens Canc Ctr, Los Angeles, CA USA

[9] Virginia Canc Specialist, Fairax, VA USA

[10] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA

[11] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

[12] Arch Oncol, Brisbane, CA USA

[13] Univ Southern Calif, Los Angeles, CA 90007 USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.2516

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2516

引用

页数：2